Folate receptor-mediated antitumor drugs

Yaoxue Xuebao

Volumn 44, Issue 2, 2009, Pages 109-114

  Jie, Zhao ^a   Sheng li, C A O ^a   Xiao lin, Zheng ^a   Bo, Zhao ^a  

^a CAPITAL NORMAL UNIVERSITY   (China)

Author keywords

Antitumor activity; Folate receptor; Folate drug conjugate; Targeted drug delivery

Indexed keywords

ANTINEOPLASTIC AGENT; DEACETYLVINBLASTINE; FOLATE RECEPTOR; CARRIER PROTEIN; CELL SURFACE RECEPTOR; DRUG CARRIER; FOLIC ACID;

ANTINEOPLASTIC ACTIVITY; CONJUGATE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG TARGETING; GENE OVEREXPRESSION; IC 50; NONHUMAN; RECEPTOR AFFINITY; REVIEW; TUMOR CELL; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FOLIC ACID; HUMANS; NEOPLASMS; RECEPTORS, CELL SURFACE; FOLATE RECEPTORS, GPI-ANCHORED;

EID: 64549126535     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Zhang Q, Xiang GY, Long N, et al. Anticancer activity of N-(phenylacetyl) doxorubicin combined with folate-targeted PGA [J], Acta Pharm Sin 2005,40: 1046-1050.
2. Leamon CP, Reddy JA. Folate-targeted chemotherapy [J], Adv Drug Deliv Rev, 2004, 56: 1127-1141.
3. Reddy J A, Allagadda VM, Leamon CP. Targeting therapeutic and imaging agents to folate receptor positive tumors [J]. Curr Pharm Biotechnol, 2005, 6: 131-150.
4. Bagnoli M, Canevari S, Figini M, et al. A step further in understanding the biology of the folate receptor in ovarian carcinoma [J]. Gynecol Oncol, 2003, 88: S140-S144.
5. Pan XQ, Zheng X, Shi G, et al. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid [J]. Blood, 2002, 100: 594-602.
6. Garin-Chesa P, Campbell I, Saigo PE, et al. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein [J]. Am J Pathol, 1993, 142: 557-567.
7. Leamon CP, Reddy JA, Vlahov IR, et al. Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate [J]. Bioconjug Chem, 2006, 17: 1226- 1232.
8. Leamon CP, Deprince RB, Hendren RW. Folate-mediated drug delivery: effect of alternative conjugation chemistry [J]. Drug Target, 1999, 7: 157-169.
9. Leamon CP, Cooper SR, Hardee GE. Folate-liposome - mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo [J]. Bioconjug Chem, 2003, 14: 738-747.
10. Lomaestro BM, Malone M. Glutathione in health and disease: pharmacotherapeutic issues [J]. Ann Pharmacother, 1995, 29: 1263-1273.
11. Cordes EH, Jencks WP. The mechanism of hydrolysis of Schiff bases derived from aliphatic amines [J]. J Am Chem Soc, 1963, 85: 2843-2848.
12. Leamon CP, Reddy JA, Vlahov IR, et al. Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic [J]. Bioconjug Chem, 2005, 16: 803-811.
13. Reddy JA, Westrick E, Leamon CP, et al. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates [J]. Cancer Chemother Pharmacol, 2006, 58: 229-236.
14. Henne WA, Kularatne SA, Low PS, et al. Synthesis and activity of a folate peptide camptothecin prodrug [J]. Bioorg Med Chem Lett, 2006, 16:5350-5355.
15. Vlahov IR, Santhapuram HKR, Kleindl PJ, et al. Design and region-selective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide [J]. Bioorg Med Chem Lett, 2006, 16: 5093-5096.
16. Leamon CP, Reddy JA, Vlahov IR, et al. Comparative preclinical activity of the folate-targeted vinca alkaloid conjugates EC 140 and EC145 [J]. Int J Cancer, 2007, 121: 1585-1592.
17. Leamon CP, Reddy JA, Vlahov IR, et al. Preclinical antitumor activity of a novel folate-targeted dual drug conjugate [J]. Mol Pharm, 2007, 4: 659-697.
18. Vlahov IR, Santhapuram HKR, Wang Y, et al. An assembly concept for the consecutive introduction of unsymmetrical disulfide bonds: synthesis of a releasable multidrug conjugate of folic acid [J]. J Org Chem, 2007, 72: 5968-5972.
19. Vite GD, Lee FY, Leamon CP. Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same: US, 20070275904 [P]. 2007-11-29.
20. Suzuki T, Hisakawa S, Itoh Y, et al. Design, synthesis, and biological activity of folate receptor-targeted prodrugs of thiolate histone deacetylase inhibitors [J]. Bioorg Med Chem Lett, 2007, 17: 4208-4212.
21. Schneider R, Schmitt F, Frochot C, et al. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel hotosensitizers for selective photodynamic therapy [J]. Bioorg Med Chem, 2005, 13: 2799-2808.